• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Corrigendum to "MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42" [Biochem. Biophys. Res. Commun. 472 (1) (2016) 262-9].

作者信息

Chou Jinjiang, Wang Bingyu, Zheng Tianjing, Li Xiaoman, Zheng Lufeng, Hu Jinhang, Zhang Yan, Xing Yingying, Xi Tao

机构信息

School of Life Science and Technology, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China.

Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, #24 Tongjiaxiang, Nanjing, 210009, People's Republic of China; Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, 210023, People's Republic of China.

出版信息

Biochem Biophys Res Commun. 2020 Jan 8;521(2):541-543. doi: 10.1016/j.bbrc.2019.10.189. Epub 2019 Nov 8.

DOI:10.1016/j.bbrc.2019.10.189
PMID:31708098
Abstract
摘要

相似文献

1
Corrigendum to "MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42" [Biochem. Biophys. Res. Commun. 472 (1) (2016) 262-9].对“MALAT1通过与cdc42竞争性结合miR-1诱导人乳腺癌细胞迁移和侵袭”[《生物化学与生物物理研究通讯》472(1)(2016)262 - 269]的勘误
Biochem Biophys Res Commun. 2020 Jan 8;521(2):541-543. doi: 10.1016/j.bbrc.2019.10.189. Epub 2019 Nov 8.
2
MALAT1 induced migration and invasion of human breast cancer cells by competitively binding miR-1 with cdc42.MALAT1通过与cdc42竞争性结合miR-1来诱导人乳腺癌细胞的迁移和侵袭。
Biochem Biophys Res Commun. 2016 Mar 25;472(1):262-9. doi: 10.1016/j.bbrc.2016.02.102. Epub 2016 Feb 27.
3
Corrigendum to "Circular RNA circMET contributes to tamoxifen resistance of breast cancer cells by targeting miR-204/AHR signaling" [Biochem. Biophys. Res. Commun. 627(2022) 200-206].对《环状RNA circMET通过靶向miR-204/AHR信号通路促进乳腺癌细胞的他莫昔芬耐药性》[生物化学与生物物理研究通讯627(2022)200 - 206]的勘误
Biochem Biophys Res Commun. 2023 Sep 10;672:210. doi: 10.1016/j.bbrc.2023.05.102. Epub 2023 Jun 15.
4
Corrigendum to "DEPDC1B enhances migration and invasion of non-small cell lung cancer cells via activating Wnt/β-catenin signaling" [Biochem. Biophys. Res. Commun. 450(1) (2014) 899-905].《“DEPDC1B通过激活Wnt/β-连环蛋白信号通路增强非小细胞肺癌细胞的迁移和侵袭”的勘误》[《生物化学与生物物理研究通讯》450(1)(2014)899 - 905]
Biochem Biophys Res Commun. 2021 Sep 3;568:195. doi: 10.1016/j.bbrc.2021.07.010. Epub 2021 Jul 14.
5
Corrigendum to "CircNUP214 sponges miR-145 to promote the expression of ZEB2 in thyroid cancer cells" [Biochem Biophys Res Commun. 507 (1-4) (2018) 168-172].《“环状核孔蛋白214通过吸附miR-145促进甲状腺癌细胞中ZEB2的表达”的勘误》[《生物化学与生物物理研究通讯》507卷第1 - 4期（2018年）168 - 172页]
Biochem Biophys Res Commun. 2019 Mar 12;510(3):488. doi: 10.1016/j.bbrc.2019.01.044. Epub 2019 Feb 2.
6
Retraction notice to "miR-613 inhibits proliferation and invasion of breast cancer cell via VEGFA" [Biochem. Biophys. Res. Commun. 478/1 (2016) 274-278].对“miR-613通过VEGFA抑制乳腺癌细胞的增殖和侵袭”[《生物化学与生物物理研究通讯》478/1 (2016) 274 - 278]的撤稿通知。
Biochem Biophys Res Commun. 2019 Aug 6;515(4):734. doi: 10.1016/j.bbrc.2018.11.192.
7
Corrigendum to "TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis" [Biochem. Biophys. Res. Commun. 491 (2) (2017) 552-557].《“TUG1通过miR - 186/CPEB2轴介导结直肠癌对甲氨蝶呤的耐药性”的勘误》[《生物化学与生物物理研究通讯》491 (2) (2017) 552 - 557]
Biochem Biophys Res Commun. 2024 Jan 8;691:149346. doi: 10.1016/j.bbrc.2023.149346. Epub 2023 Dec 3.
8
Corrigendum to "Pseudogene CYP4Z2P 3'UTR promotes angiogenesis in breast cancer." [Biochem. Biophys. Res. Commun. 2014 oct 24, 453(3), 545-51].《“假基因CYP4Z2P 3'非翻译区促进乳腺癌血管生成”的勘误》[《生物化学与生物物理研究通讯》2014年10月24日，453(3)，545 - 51]
Biochem Biophys Res Commun. 2020 Jan 8;521(2):546-547. doi: 10.1016/j.bbrc.2019.10.131. Epub 2019 Oct 28.
9
Corrigendum to "MiR-429 regulates blood-spinal cord barrier permeability by targeting Krüppel-like factor 6" [Biochem. Biophys. Res. Commun.(2020)].《“MiR-429通过靶向Krüppel样因子6调节血脊髓屏障通透性”的勘误》[《生物化学与生物物理研究通讯》（2020年）]
Biochem Biophys Res Commun. 2020 Jun 30;527(3):845. doi: 10.1016/j.bbrc.2020.04.110. Epub 2020 May 18.
10
Corrigendum to "Shikonin attenuates sympathetic remodeling in chronic heart failure mice via regulating miR-124" [Biochem. Biophys. Res. Commun. 520(2) (2019) 359-365].
Biochem Biophys Res Commun. 2022 Aug 27;618:153-154. doi: 10.1016/j.bbrc.2022.06.048. Epub 2022 Jun 19.